MCF Advisors’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$73.8K Buy
3,101
+454
+17% +$8.71K ﹤0.01% 599
2026
Q1
$46.6K Hold
2,647
﹤0.01% 622
2025
Q4
$52.3K Buy
2,647
+45
+2% +$808 ﹤0.01% 503
2025
Q3
$45.4K Buy
2,602
+72
+3% +$1.07K ﹤0.01% 447
2025
Q2
$35.4K Buy
2,530
+365
+17% +$5.88K ﹤0.01% 462
2025
Q1
$40.3K Buy
2,165
+1,011
+88% +$15.1K ﹤0.01% 425
2024
Q4
$13K Buy
+1,154
New +$13.5K ﹤0.01% 620

Other funds holding ALHC

MCF Advisors's ALHC Position: Q2 2026 in Review

MCF Advisors increased its Alignment Healthcare (ALHC) stake by 17% in Q2 2026, buying an estimated $8.71K and bringing the position to 3,101 shares worth $73.8K. The position accounts for ﹤0.01% of the portfolio, ranked #599.

MCF Advisors first reported a position in ALHC in Q4 2024 and has held it in 7 quarters since. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • MCF Advisors held 3,101 shares of Alignment Healthcare worth $73.8K as of Q2 2026.
  • MCF Advisors bought 454 Alignment Healthcare shares in Q2 2026, an estimated $8.71K.
  • Alignment Healthcare made up ﹤0.01% of MCF Advisors's portfolio in Q2 2026, its #599 holding.
  • MCF Advisors first reported a position in Alignment Healthcare in Q4 2024 and has held it in 7 quarters since.
  • 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.